Hit to lead
Hit to Lead (H2L) is a process in Drug Discovery and Pharmacology that involves the identification of active, but chemically simple compounds, and their subsequent refinement into more potent and selective chemical entities. This process is a critical step in the development of new Medicinal Drugs.
Overview
The Hit to Lead process begins with the identification of a 'hit', a compound that demonstrates some level of activity against a chosen Biological Target. This hit is typically identified through High-Throughput Screening (HTS) of large libraries of compounds. Once a hit has been identified, it is then optimized through a process of Medicinal Chemistry to improve its potency, selectivity, and pharmacokinetic properties. This optimized compound is known as a 'lead'.
Hit Identification
Hit identification is the first step in the Hit to Lead process. This involves the screening of large libraries of compounds against a chosen biological target. The aim of this step is to identify compounds that show some level of activity against the target. This is typically achieved through the use of High-Throughput Screening (HTS), a process that allows for the rapid testing of large numbers of compounds.
Lead Optimization
Once a hit has been identified, it is then optimized to improve its potency, selectivity, and pharmacokinetic properties. This is achieved through a process of Medicinal Chemistry, which involves the systematic modification of the hit compound's chemical structure. The aim of this process is to produce a 'lead' compound that is suitable for further development.
Challenges
The Hit to Lead process is not without its challenges. One of the main challenges is the need to balance potency and selectivity with acceptable pharmacokinetic properties. This often requires a process of iterative design and testing, which can be time-consuming and costly. Additionally, the process is often complicated by the need to consider potential Toxicity and Side Effects of the lead compound.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD